[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569123":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":40,"locations":46,"responsibleParty":199,"collaborators":201,"id":209,"slug":210,"hasResults":211,"nctId":212,"briefTitle":213,"officialTitle":214,"acronym":215,"eligibilityCriteria":216,"healthyVolunteers":211,"sex":217,"minAge":10,"maxAge":10,"enrollmentInfo":218,"targetDuration":10,"studyType":221,"phases":10,"briefSummary":222,"conditions":223,"keywords":226,"overallStatus":48,"whyStopped":10,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":234,"completionDateStruct":236,"leadSponsor":238,"locationsCount":239},{"fullName":5,"class":6},"Nantes University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study population (Newborns with congenital heart defects and their two parents)",null,"The study population will consist of 150 fetuses with a prenatally diagnosed critical congenital heart defect (CHD), at high risk of developing developmental delays, and their two parents.",[13,14,15,16,17],"Behavioral: Neurodevelopmental assessment (Bayley-IV)","Other: Biological sampling","Behavioral: ELFE dietary questionnaire","Behavioral: Post-Traumatic Stress Questionnaire IES-R (Impact of Event Scale - Revised)","Other: Data collection for the study (Cardiovascular, developemental, fetal, pregnancy, MRI)",[19,24,28,32,36],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"BEHAVIORAL","Neurodevelopmental assessment (Bayley-IV)","Assessment of developmental delays through administration of the Bayley-4 test by a neuropsychologist",[9],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Biological sampling","The samples to be collected at delivery will include:\n\n* A 4 ml maternal blood sample in an EDTA tube for lipidomic and metabolomic analyses at delivery\n* A 6 ml maternal blood sample in an EDTA tube (2 tubes of 3 ml) for genetic analysis\n* A 4 ml venous cord blood sample in an EDTA tube for transcriptomic and epigenetic analysis; and a 2 ml EDTA tube for metabolomic\u002Flipidomic analysis\n* Samples from fresh placenta for transcriptomic, epigenetic, metabolomic, and lipidomic analyses\n* A meconium sample collected as soon as possible after birth in a dry tube for microbiome analysis\n\nDuring hospitalization for the cardiac surgery:\n\n* Genome analysis samples will be collected from the father and the infant. These samples will be taken in two EDTA tubes of 3 ml each.\n* Perioperative neurobiomarker samples will be collected (one EDTA tube of 500 μL preoperatively and postoperatively on Day 1 and 2).\n\nAt 1 month, a stool sample will be collected from the infants for microbiome analysis.",[9],{"type":20,"name":29,"description":30,"armGroupLabels":31,"otherNames":10},"ELFE dietary questionnaire","Questionnaire on diet and lifestyle during pregnancy (only for the mother)",[9],{"type":20,"name":33,"description":34,"armGroupLabels":35,"otherNames":10},"Post-Traumatic Stress Questionnaire IES-R (Impact of Event Scale - Revised)","The IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events.",[9],{"type":6,"name":37,"description":38,"armGroupLabels":39,"otherNames":10},"Data collection for the study (Cardiovascular, developemental, fetal, pregnancy, MRI)","* Cardiovascular follow-up data collection\n* Developmental follow-up data collection\n* Collection of postoperative brain MRI data, scheduled between Day 5 post-surgery and the end of the hospital stay\n* Collection of data on pregnancy exposure, obstetric events, and delivery data.\n* Collection of fetal ultrasound data (T2 and T3).\n* Collection of fetal echocardiography data (T2 and T3).",[9],[41],{"name":42,"role":43,"phone":44,"phoneExt":10,"email":45},"Alban Baruteau","CONTACT","+33 2 40 08 77 42","albanelouen.baruteau@chu-nantes.fr",[47,75,95,110,126,144,159,183],{"facility":5,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"RECRUITING","Nantes","Loire Atlantique","44093","France","FR",{"type":55,"coordinates":56},"Point",[57,58],-1.55336,47.21725,{"lat":58,"lon":57},[61,64,66,69,71,73],{"name":62,"role":43,"phone":63,"phoneExt":10,"email":45},"Alban BARUTEAU","+33 253482835",{"name":62,"role":65,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":67,"role":68,"phone":10,"phoneExt":10,"email":10},"Oscar WERNER","SUB_INVESTIGATOR",{"name":70,"role":68,"phone":10,"phoneExt":10,"email":10},"Bénédicte ROMEFORT",{"name":72,"role":68,"phone":10,"phoneExt":10,"email":10},"Nadir BENBRIK",{"name":74,"role":68,"phone":10,"phoneExt":10,"email":10},"Norbert WINER",{"facility":76,"status":48,"city":77,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"CHU de Bordeaux","Bordeaux",{"type":55,"coordinates":79},[80,81],-0.58046,44.84124,{"lat":81,"lon":80},[84,88,89,91,93],{"name":85,"role":43,"phone":86,"phoneExt":10,"email":87},"Marion AUDIE","+33 556795679","marion.audie@chu-bordeaux.fr",{"name":85,"role":65,"phone":10,"phoneExt":10,"email":10},{"name":90,"role":68,"phone":10,"phoneExt":10,"email":10},"Caroline Thambo-Rooryck",{"name":92,"role":68,"phone":10,"phoneExt":10,"email":10},"Julie THOMAS-CHABANEIX",{"name":94,"role":65,"phone":10,"phoneExt":10,"email":10},"Loïc SENTILHES",{"facility":96,"status":48,"city":97,"state":10,"zip":98,"country":52,"countryCode":53,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"APHP - Antoine Béclère","Clamart","92140",{"type":55,"coordinates":100},[101,102],2.26692,48.80299,{"lat":102,"lon":101},[105,109],{"name":106,"role":43,"phone":107,"phoneExt":10,"email":108},"Alexandre VIVANTI","+33 145374366","alexandre.vivanti@aphp.fr",{"name":106,"role":65,"phone":10,"phoneExt":10,"email":10},{"facility":111,"status":48,"city":112,"state":10,"zip":113,"country":52,"countryCode":53,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Hôpital Marie Lannelongue","Le Plessis-Robinson","92350",{"type":55,"coordinates":115},[116,117],2.27078,48.78889,{"lat":117,"lon":116},[120,124],{"name":121,"role":43,"phone":122,"phoneExt":10,"email":123},"Sébastien HASCOËT","+33 140942429","s.hascoet@ghpsj.fr",{"name":125,"role":65,"phone":10,"phoneExt":10,"email":10},"Sébastien HASCOUËT",{"facility":127,"status":48,"city":128,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"AP-HM","Marseille",{"type":55,"coordinates":130},[131,132],5.38107,43.29695,{"lat":132,"lon":131},[135,139,140,142],{"name":136,"role":43,"phone":137,"phoneExt":10,"email":138},"Caroline OVAERT","+334 91386496","caroline.ovaert@ap-hm.fr",{"name":136,"role":65,"phone":10,"phoneExt":10,"email":10},{"name":141,"role":65,"phone":10,"phoneExt":10,"email":10},"Florence BRETELLE",{"name":143,"role":68,"phone":10,"phoneExt":10,"email":10},"Béatrice DESNOUS",{"facility":145,"status":146,"city":147,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"AP-HP Necker","NOT_YET_RECRUITING","Paris",{"type":55,"coordinates":149},[150,151],2.3488,48.85341,{"lat":151,"lon":150},[154,158],{"name":155,"role":43,"phone":156,"phoneExt":10,"email":157},"Damien BONNET","+33 144494344","Damien.bonnet@aphp.fr",{"name":155,"role":65,"phone":10,"phoneExt":10,"email":10},{"facility":160,"status":146,"city":161,"state":10,"zip":162,"country":52,"countryCode":53,"cosmosGeoPoint":163,"geoPoint":167,"contacts":168},"CHU de Toulouse","Toulouse","31000",{"type":55,"coordinates":164},[165,166],1.44367,43.60426,{"lat":166,"lon":165},[169,173,177,179,181,182],{"name":170,"role":43,"phone":171,"phoneExt":10,"email":172},"Khaled HADEED","+33 5 34 55 74 73","Hadeed.k@chu-toulouse.fr",{"name":174,"role":43,"phone":175,"phoneExt":10,"email":176},"Paul GUERBY","+33 567771106","guerby.p@chu-toulouse.fr",{"name":178,"role":68,"phone":10,"phoneExt":10,"email":10},"Clément KARSENTY",{"name":180,"role":68,"phone":10,"phoneExt":10,"email":10},"Yves DULAC",{"name":174,"role":65,"phone":10,"phoneExt":10,"email":10},{"name":170,"role":65,"phone":10,"phoneExt":10,"email":10},{"facility":184,"status":48,"city":185,"state":10,"zip":10,"country":52,"countryCode":53,"cosmosGeoPoint":186,"geoPoint":190,"contacts":191},"CHRU Tours","Tours",{"type":55,"coordinates":187},[188,189],0.70398,47.39484,{"lat":189,"lon":188},[192,196,198],{"name":193,"role":43,"phone":194,"phoneExt":10,"email":195},"Bruno LEFORT","+33 247474755","b.lefort@univ-tours.fr",{"name":197,"role":65,"phone":10,"phoneExt":10,"email":10},"Franck PERROTIN",{"name":193,"role":65,"phone":10,"phoneExt":10,"email":10},{"type":200,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[202,205,207],{"name":203,"class":204},"Pays de la Loire Laboratory of Psychology (LPPL)","UNKNOWN",{"name":206,"class":204},"Physiopathology of Nutritional Adaptations Joint Research Unit (UMR PhAN)",{"name":208,"class":204},"Institut du thorax, INSERM UMR1087","100569123","characterization-and-support-of-neurodevelopmental-disorders-associated-with-congenital-cardiac-malformations---neonatal-100569123",false,"NCT06690151","Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal","CATAMARAN - Neonatal Cohort : Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal","CATAMARAN - NN","The inclusion criteria are as follows:\n\n* Fetus with a congenital heart defect (CHD) detected prenatally (prenatal diagnosis of the heart defect)\n* Fetus with a critical CHD defined as requiring cardiac surgery during the first three months of the infant's life\n* Parents affiliated with or beneficiaries of a social security or equivalent system\n* Parents' good understanding of the French language\n* Voluntary, informed, and written consent from both parents for themselves and the unborn child\n\nCriteria for parents\\*:\n\n\\- Biological parents \\*The inclusion of the father in the project does not limit the participation of the child (patient) in the study.\n\n\\*The father will be encouraged to participate in the project by providing a blood sample to create a trio (mother\u002Ffather\u002Finfant) for future genetic analyses.\n\nHowever, if the father is unavailable or does not consent to the collection and storage of samples for analysis (as part of the CATAMARAN study or future research projects related to biobanking), the child can still be included in the study.\n\nExclusion Criteria:\n\n* Medical termination of pregnancy considered\n* Genetic anomaly or malformative syndrome identified prior to inclusion","ALL",{"count":219,"type":220},450,"ESTIMATED","OBSERVATIONAL","Congenital heart defects (CHD), as the leading cause of birth defects, affect 12 million people globally and approximately 41,000 newborns each year in Europe. CHD presents a significant public health concern due to its association with high morbidity and mortality rates across the lifespan. Over 50% of infants born with critical CHD will develop neurodevelopmental disorders (NDD), requiring specialized care and impacting their quality of life. NDDs, involving early and persistent disruptions in cognitive, emotional, and behavioral development due to abnormal brain development, are highly variable. They may impact language, learning, motor skills, intellectual efficiency, social cognition, attention, memory, and executive functions, often accompanied by psychosocial difficulties. These hidden disabilities constitute the primary long-term sequelae of CHD, surpassing even cardiovascular complications in impact, and affect children who often undergo multiple cardiac surgeries during early childhood. NDDs are associated not only with complex CHDs but also with simpler CHDs that are repaired in early childhood and considered 'cured.'\n\nThe origin of CHD-associated NDDs remains largely unknown. While few genetic or environmental causes have been identified, recent research suggests a possible common origin linking heart malformations and neurodevelopmental abnormalities. The CATAMARAN neonatal cohort project aims to detect developmental delays associated with CHD as early as six months of age and to identify both individual susceptibility factors and acquired vulnerabilities contributing to the development of NDDs in infants with CHD.",[224,225],"Heart Disease Congenital","Neurodevelopmental Disorder",[227,228,229],"Congenital heart defects (CHD)","neurodevelopmental disorders (NDD)","genetics","2026-06-30",{"date":232,"type":233},"2026-07-01","ACTUAL",{"date":235,"type":233},"2025-02-28",{"date":237,"type":220},"2028-08-28",{"name":5,"class":6},8]